The Daily Pulse

General

Online healthcare provider Voy faces advertising ban over low testosterone test claims

Reported by Sneha Patil (Staff Writer) · BBC News - UK ·

Source: BBC News
Worth knowing
Online healthcare provider Voy faces advertising ban over low testosterone test claimsPhoto: Openverse - flickr

The Advertising Standards Authority has banned five adverts by online healthcare provider Voy for making misleading claims about low testosterone in men. ## Adverts and Claims The banned promotions included three posters and two paid-for Facebook ads for at-home testosterone blood tests. The watchdog stated the ads misleadingly linked common symptoms like fatigue, irritability, low sex drive, low energy, loss of motivation, and mood changes to low testosterone. One Facebook ad also claimed that low testosterone affects one in four men over 30, which the regulator found unsupported by evidence. ## Company Response Dr Earim Chaudry, the chief medical officer for Voy, stated that patient decisions at the company are clinician-led and that the campaigns were designed to align with UK advertising standards. The company stated it withdrew the adverts while the investigation was happening and will not run them again. Earlier this year, some of these ads appeared on the London Underground and drew online backlash and criticism for phrases such as "It's not him, it's his hormones" and "Men get hormonal too." At the time, Voy stated it aimed to destigmatise conversations about men's health. ## Context This ruling follows two similar decisions in August against other online providers, BioID Health and Numan Digital Healthcare. The Advertising Standards Authority states that while low testosterone tests and services are permitted, companies must ensure their claims rely on proper evidence. Medical experts note that testosterone levels can easily appear low in healthy men depending on the time of day, meals, illness, or lack of sleep.

Read more at BBC News - UK →